Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Timing of Optimal Platelet Inhibition After Acute Coronary Syndrome (TOPIC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02099422
Recruitment Status : Unknown
Verified March 2014 by CUISSET Thomas, Hôpital de la Timone.
Recruitment status was:  Recruiting
First Posted : March 28, 2014
Last Update Posted : March 28, 2014
Sponsor:
Information provided by (Responsible Party):
CUISSET Thomas, Hôpital de la Timone

Brief Summary:
Comparison of two antiplatelet strategies between months 1 and 12 after coronary stenting for ACS. Efficiency and tolerance évaluation

Condition or disease
Acute Coronary Syndrome Coronary Stenting Antiplatelet Therapy

Layout table for study information
Study Type : Observational
Estimated Enrollment : 500 participants
Observational Model: Case Control
Time Perspective: Prospective
Official Title: The Randomized TOPIC Study : Timing of Optimal Platelet Inhibition After Acute Coronary Syndrome
Study Start Date : January 2013
Estimated Primary Completion Date : January 2015
Estimated Study Completion Date : January 2016



Primary Outcome Measures :
  1. combined ischemic and hemorragic endpoint [ Time Frame: 12 months ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 85 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Sampling Method:   Non-Probability Sample
Study Population
Patients with ACS treated by coronary stent implantation
Criteria

Inclusion Criteria:

  • ACS and coronary stenting one month ago

Exclusion Criteria:

  • age under 18 and pregnancy

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02099422


Contacts
Layout table for location contacts
Contact: thomas cuisset, MD-PHD 33(0) 491385981 thomas.cuisset@ap-hm.fr

Locations
Layout table for location information
France
CHU Timone hospital . Sc CARDIOLOGIE. Rue saint Pierre. Recruiting
Marseille, France, 13005
Contact: thomas cuisset, MD-PHD    33(0)491385981    thomas.cuisset@ap-hm.fr   
Principal Investigator: thomas cuisset, MD-PHD         
Sponsors and Collaborators
Hôpital de la Timone

Layout table for additonal information
Responsible Party: CUISSET Thomas, MD-PHD, Hôpital de la Timone
ClinicalTrials.gov Identifier: NCT02099422     History of Changes
Other Study ID Numbers: APHM-011
2013-A01168-37 ( Other Identifier: AFSSAPS )
First Posted: March 28, 2014    Key Record Dates
Last Update Posted: March 28, 2014
Last Verified: March 2014

Additional relevant MeSH terms:
Layout table for MeSH terms
Syndrome
Acute Coronary Syndrome
Disease
Pathologic Processes
Myocardial Ischemia
Heart Diseases
Cardiovascular Diseases
Vascular Diseases